Andrew R Allen - Net Worth and Insider Trading
Andrew R Allen Net Worth
The estimated net worth of Andrew R Allen is at least $154,572 dollars as of 2024-11-05. Andrew R Allen is the Director of Sierra Oncology Inc and owns about 1,650 shares of Sierra Oncology Inc (SRRA) stock worth over $90,734. Andrew R Allen is the PRESIDENT AND CEO of Gritstone Bio Inc and owns about 2,434,635 shares of Gritstone Bio Inc (GRTSQ) stock worth over $61,109. Andrew R Allen is also the See Remarks of Clovis Oncology Inc and owns about 181,919 shares of Clovis Oncology Inc (CLVSQ) stock worth over $2,729. Details can be seen in Andrew R Allen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew R Allen has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew R Allen
Andrew R Allen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew R Allen owns 6 companies in total, including Sierra Oncology Inc (SRRA) , Epizyme Inc (EPZM) , and Gritstone Bio Inc (GRTSQ) among others .
Click here to see the complete history of Andrew R Allen’s form 4 insider trades.
Insider Ownership Summary of Andrew R Allen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2018-12-10 | director |
| EPZM | Epizyme Inc | 2019-05-31 | director |
| GRTSQ | Gritstone Bio Inc | 2024-05-16 | director & President and CEO |
 | | 2019-02-13 | director |
| | 2013-06-05 | SEE REMARKS |
| | 2023-06-01 | director |
Andrew R Allen Latest Holdings Summary
Andrew R Allen currently owns a total of 3 stocks. Among these stocks, Andrew R Allen owns 1,650 shares of Sierra Oncology Inc (SRRA) as of December 10, 2018, with a value of $90,734 and a weighting of 58.7%. Andrew R Allen owns 2,434,635 shares of Gritstone Bio Inc (GRTSQ) as of May 16, 2024, with a value of $61,109 and a weighting of 39.53%. Andrew R Allen also owns 181,919 shares of Clovis Oncology Inc (CLVSQ) as of June 5, 2013, with a value of $2,729 and a weighting of 1.77%.
Latest Holdings of Andrew R Allen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2018-12-10 | 1,650 | 54.99 | 90,734 |
| GRTSQ | Gritstone Bio Inc | 2024-05-16 | 2,434,635 | 0.03 | 61,109 |
| CLVSQ | Clovis Oncology Inc | 2013-06-05 | 181,919 | 0.02 | 2,729 |
Holding Weightings of Andrew R Allen
Andrew R Allen Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew R Allen has made a total of 0 transactions in Sierra Oncology Inc (SRRA) over the past 5 years. The most-recent trade in Sierra Oncology Inc is the acquisition of 1,650 shares on December 10, 2018, which cost Andrew R Allen around $108,240.
According to the SEC Form 4 filings, Andrew R Allen has made a total of 1 transactions in Gritstone Bio Inc (GRTSQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Gritstone Bio Inc is the sale of 24,263 shares on May 16, 2024, which brought Andrew R Allen around $18,197.
According to the SEC Form 4 filings, Andrew R Allen has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 22,594 shares on June 5, 2013, which brought Andrew R Allen around $2 Million.
Insider Trading History of Andrew R Allen
- 1
Andrew R Allen Trading Performance
GuruFocus tracks the stock performance after each of Andrew R Allen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew R Allen is 54%. GuruFocus also compares Andrew R Allen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew R Allen within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew R Allen's insider trading performs compared to the benchmark.
Performance of Andrew R Allen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.22 | | | | | |
| Relative Return to S&P 500(%) | -1.13 | | | | | |
Andrew R Allen Ownership Network
Ownership Network List of Andrew R Allen
Ownership Network Relation of Andrew R Allen
Andrew R Allen Owned Company Details
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Andrew R Allen is the director of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
Andrew R Allen Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew R Allen. You might contact Andrew R Allen via mailing address: 2525 28th Street, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
